FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia

Fanconi anemia is a rare hereditary disease showing genetic heterogeneity due to a variety of mutations in genes involved in DNA repair pathways, which may lead to different clinical manifestations. Phenotypic variability makes diagnosis difficult based only on clinical manifestations, therefore laboratory tests are necessary. New advances in molecular pathogenesis of this disease led researchers to develop a diagnostic test based on Western blot for FANCD2. The objective of the present study was to determine the efficacy of this method for the diagnosis of 84 Brazilian patients with Fanconi anemia, all of whom tested positive for the diepoxybutane test, and 98 healthy controls. The FANCD2 monoubiquitinated isoform (FANCDS+/FANCD2L-) was not detected in 77 patients (91.7%). In 2 patients (2.4%), there was an absence of both the monoubiquitinated and the non-ubiquitinated proteins (FANCD2S-/FANCD2L-) and 5 patients (5.9%) had both isoforms (FANCD2S+/FANCD2L+). This last phenotype suggests downstream subtypes or mosaicism. All controls were diepoxybutane negative and were also negative on the FANCD2 Western blot. The Western blot for FANCD2 presented a sensitivity of 94% (79/84) and specificity of 100% (98/98). This method was confirmed as an efficient approach to screen Brazilian patients with deleterious mutations on FANCD2 (FANCD2S-/FANCD2L-) or other upstream genes of the FA/BRCA pathway (FANCDS+/FANCD2L-), to confirm the chromosome breakage test and to classify patients according to the level of FA/BRCA pathway defects. However, patients showing both FANCD2 isoforms (FANCD2S+/FANCD2L+) require additional studies to confirm mutations on downstream Fanconi anemia genes or the presence of mosaicism.

Saved in:
Bibliographic Details
Main Authors: Pilonetto,D.V., Pereira,N.F., Bitencourt,M.A., Magdalena,N.I.R., Vieira,E.R., Veiga,L.B.A., Cavalli,I.J., Ribeiro,R.C., Pasquini,R.
Format: Digital revista
Language:English
Published: Associação Brasileira de Divulgação Científica 2009
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000300004
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-879X2009000300004
record_format ojs
spelling oai:scielo:S0100-879X20090003000042009-03-12FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemiaPilonetto,D.V.Pereira,N.F.Bitencourt,M.A.Magdalena,N.I.R.Vieira,E.R.Veiga,L.B.A.Cavalli,I.J.Ribeiro,R.C.Pasquini,R. Fanconi anemia FANCD2 Western blot Diepoxybutane test Monoubiquitination Immunoblotting Fanconi anemia is a rare hereditary disease showing genetic heterogeneity due to a variety of mutations in genes involved in DNA repair pathways, which may lead to different clinical manifestations. Phenotypic variability makes diagnosis difficult based only on clinical manifestations, therefore laboratory tests are necessary. New advances in molecular pathogenesis of this disease led researchers to develop a diagnostic test based on Western blot for FANCD2. The objective of the present study was to determine the efficacy of this method for the diagnosis of 84 Brazilian patients with Fanconi anemia, all of whom tested positive for the diepoxybutane test, and 98 healthy controls. The FANCD2 monoubiquitinated isoform (FANCDS+/FANCD2L-) was not detected in 77 patients (91.7%). In 2 patients (2.4%), there was an absence of both the monoubiquitinated and the non-ubiquitinated proteins (FANCD2S-/FANCD2L-) and 5 patients (5.9%) had both isoforms (FANCD2S+/FANCD2L+). This last phenotype suggests downstream subtypes or mosaicism. All controls were diepoxybutane negative and were also negative on the FANCD2 Western blot. The Western blot for FANCD2 presented a sensitivity of 94% (79/84) and specificity of 100% (98/98). This method was confirmed as an efficient approach to screen Brazilian patients with deleterious mutations on FANCD2 (FANCD2S-/FANCD2L-) or other upstream genes of the FA/BRCA pathway (FANCDS+/FANCD2L-), to confirm the chromosome breakage test and to classify patients according to the level of FA/BRCA pathway defects. However, patients showing both FANCD2 isoforms (FANCD2S+/FANCD2L+) require additional studies to confirm mutations on downstream Fanconi anemia genes or the presence of mosaicism.info:eu-repo/semantics/openAccessAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research v.42 n.3 20092009-03-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000300004en10.1590/S0100-879X2009000300004
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Pilonetto,D.V.
Pereira,N.F.
Bitencourt,M.A.
Magdalena,N.I.R.
Vieira,E.R.
Veiga,L.B.A.
Cavalli,I.J.
Ribeiro,R.C.
Pasquini,R.
spellingShingle Pilonetto,D.V.
Pereira,N.F.
Bitencourt,M.A.
Magdalena,N.I.R.
Vieira,E.R.
Veiga,L.B.A.
Cavalli,I.J.
Ribeiro,R.C.
Pasquini,R.
FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
author_facet Pilonetto,D.V.
Pereira,N.F.
Bitencourt,M.A.
Magdalena,N.I.R.
Vieira,E.R.
Veiga,L.B.A.
Cavalli,I.J.
Ribeiro,R.C.
Pasquini,R.
author_sort Pilonetto,D.V.
title FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
title_short FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
title_full FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
title_fullStr FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
title_full_unstemmed FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia
title_sort fancd2 western blot as a diagnostic tool for brazilian patients with fanconi anemia
description Fanconi anemia is a rare hereditary disease showing genetic heterogeneity due to a variety of mutations in genes involved in DNA repair pathways, which may lead to different clinical manifestations. Phenotypic variability makes diagnosis difficult based only on clinical manifestations, therefore laboratory tests are necessary. New advances in molecular pathogenesis of this disease led researchers to develop a diagnostic test based on Western blot for FANCD2. The objective of the present study was to determine the efficacy of this method for the diagnosis of 84 Brazilian patients with Fanconi anemia, all of whom tested positive for the diepoxybutane test, and 98 healthy controls. The FANCD2 monoubiquitinated isoform (FANCDS+/FANCD2L-) was not detected in 77 patients (91.7%). In 2 patients (2.4%), there was an absence of both the monoubiquitinated and the non-ubiquitinated proteins (FANCD2S-/FANCD2L-) and 5 patients (5.9%) had both isoforms (FANCD2S+/FANCD2L+). This last phenotype suggests downstream subtypes or mosaicism. All controls were diepoxybutane negative and were also negative on the FANCD2 Western blot. The Western blot for FANCD2 presented a sensitivity of 94% (79/84) and specificity of 100% (98/98). This method was confirmed as an efficient approach to screen Brazilian patients with deleterious mutations on FANCD2 (FANCD2S-/FANCD2L-) or other upstream genes of the FA/BRCA pathway (FANCDS+/FANCD2L-), to confirm the chromosome breakage test and to classify patients according to the level of FA/BRCA pathway defects. However, patients showing both FANCD2 isoforms (FANCD2S+/FANCD2L+) require additional studies to confirm mutations on downstream Fanconi anemia genes or the presence of mosaicism.
publisher Associação Brasileira de Divulgação Científica
publishDate 2009
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2009000300004
work_keys_str_mv AT pilonettodv fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT pereiranf fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT bitencourtma fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT magdalenanir fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT vieiraer fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT veigalba fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT cavalliij fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT ribeirorc fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
AT pasquinir fancd2westernblotasadiagnostictoolforbrazilianpatientswithfanconianemia
_version_ 1756391246489714688